Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Bio Essence (BIOE) Non Operating Income (2020 - 2025)

Bio Essence has reported Non Operating Income over the past 6 years, most recently at -$540.0 for Q4 2025.

  • For Q4 2025, Non Operating Income rose 98.28% year-over-year to -$540.0; the TTM value through Dec 2025 reached -$3014.0, up 99.73%, while the annual FY2025 figure was -$3014.0, 99.73% up from the prior year.
  • Non Operating Income for Q4 2025 was -$540.0 at Bio Essence, up from -$1255.0 in the prior quarter.
  • Over five years, Non Operating Income peaked at $28842.0 in Q1 2024 and troughed at -$1.1 million in Q3 2024.
  • A 5-year average of -$58712.6 and a median of -$957.5 in 2025 define the central range for Non Operating Income.
  • Biggest five-year swings in Non Operating Income: soared 8660.42% in 2022 and later tumbled 36703.01% in 2023.
  • Year by year, Non Operating Income stood at $48.0 in 2021, then soared by 8660.42% to $4205.0 in 2022, then skyrocketed by 195.55% to $12428.0 in 2023, then crashed by 352.78% to -$31415.0 in 2024, then soared by 98.28% to -$540.0 in 2025.
  • Business Quant data shows Non Operating Income for BIOE at -$540.0 in Q4 2025, -$1255.0 in Q3 2025, and -$559.0 in Q2 2025.